General Publications
05/18/2010
Antibiotic Management of Staphylococcus aureus Infections in US Children's Hospitals, 1999–2008
Joshua C. Herigon, MPH, Adam L. Hersh, MD, PhD, Jeffrey S. Gerber, MD, PhD, Theoklis E. Zaoutis, MD, MSCE, Jason G. Newland, MD
PEDIATRICS (doi:10.1542/peds.2009-2867)
View abstract at pediatrics.aappublications.org
Joshua C. Herigon, MPH, Adam L. Hersh, MD, PhD, Jeffrey S. Gerber, MD, PhD, Theoklis E. Zaoutis, MD, MSCE, Jason G. Newland, MD
PEDIATRICS (doi:10.1542/peds.2009-2867)
View abstract at pediatrics.aappublications.org
09/01/2009
Has the era of untreatable infections arrived?
David M. Livermore
The Journal of Antimicrobial Chemotherapy (2009), 64 Suppl 1, i29-36.
Access this publication at OxfordJournals.org
David M. Livermore
The Journal of Antimicrobial Chemotherapy (2009), 64 Suppl 1, i29-36.
Access this publication at OxfordJournals.org
07/21/2009
Physicochemical properties of antibacterial compounds: implications for drug discovery
R. O'Shea, H.E. Moser
Journal of Medicinal Chemistry (2008), 51(10), 2871-2878.
Access this publication at pubs.acs.org
R. O'Shea, H.E. Moser
Journal of Medicinal Chemistry (2008), 51(10), 2871-2878.
Access this publication at pubs.acs.org
04/05/2008
Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes
Dror Marchaim, Shiri Navon-Venezia, Mitchell J. Schwaber, and Yehuda Carmeli
Antimicrobial Agents and Chemotherapy, April 2008, p. 1413-1418, Vol. 52, No. 4
Access this publication at aac.asm.org
